Evidence map›Paper›PMID 22560224›Full record

ArticleCell metabolism2012

Ablation of steroid receptor coactivator-3 resembles the human CACT metabolic myopathy.

Brian York, Erin L Reineke, Jørn V Sagen, Bryan C Nikolai, Suoling Zhou, Jean-Francois Louet, Atul R Chopra, Xian Chen, Graham Reed, Jeffrey Noebels and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell metabolism, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 37 citations in OpenAlex.

  1. Androgens as the "old age stick" in skeletal muscle.Cell communication and signaling : CCS · 2025
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 2 countries.

Brian YorkDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Erin L Reineke
Jørn V Sagen
Bryan C Nikolai
Suoling Zhou
Jean-Francois Louet
Atul R Chopra
Xian Chen
Graham Reed
Jeffrey Noebels
Adekunle M Adesina
Hui Yu
Lee-Jun C Wong
Anna Tsimelzon
Susan Hilsenbeck
Robert D Stevens
Brett R Wenner
Olga Ilkayeva
Jianming Xu
Christopher B Newgard
Bert W O'Malley
Baylor College of Medicine · USDuke University · USHaukeland University Hospital · NOTexas Children's Hospital · US

Funding

ProteomicsU19DK062434 · NIDDK · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI MANGELSDORF, DAVID J · 2002 to 2011
$37.4M
UNDERSTANDING FXTAS AMONG MALES WITH THE FMR1 PREMUTATIONP30HD024064 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI BEAUDET, ARTHUR L. · 1988 to 2013
$29.4M
REPRODUCTIVE HORMONES: BIOLOGICAL AND MOLECULAR ACTIONSR01HD008188 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI DAVID M LONARD, JOHN P LYDON · 1985 to 2026
$16.3M
SEX HORMONE RECEPTOR COMPONENTS AND THE CELL GENOMER01HD007857 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI DAVID M LONARD, JOHN P LYDON · 1985 to 2026
$14.6M
PLASTICITY IN DEVELOPING EPILEPTIC BRAINR01NS029709 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI NOEBELS, JEFFREY · 1991 to 2025
$9.1M
Diabetes Endocrinology Research CenterP30DK079638 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI CHAN, LAWRENCE · 2008 to 2012
$6.4M
The Role of SRC-1 in Breast CancerR01CA112403 · NCI · BAYLOR COLLEGE OF MEDICINE · PI XU, JIANMING · 2006 to 2016
$2.9M
Roles of SRC-3 in Development and DiseaseR01DK058242 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI XU, JIANMING · 2000 to 2013
$2.8M
NCI NIH HHS R01 CA112403NICHD NIH HHS P01 HD08818-37NICHD NIH HHS R01 HD007857NICHD NIH HHS R01 HD008188NICHD NIH HHS R01HD8188-38S1NIDDK NIH HHS P30 DK079638NIDDK NIH HHS R01 DK058242NIDDK NIH HHS U19 DK062434NIDDK NIH HHS U19 DK62434-08NINDS NIH HHS R01 NS029709
6 · The paper itself

Abstract

Oxidation of lipid substrates is essential for survival in fasting and other catabolic conditions, sparing glucose for the brain and other glucose-dependent tissues. Here we show Steroid Receptor Coactivator-3 (SRC-3) plays a central role in long chain fatty acid metabolism by directly regulating carnitine/acyl-carnitine translocase (CACT) gene expression. Genetic deficiency of CACT in humans is accompanied by a constellation of metabolic and toxicity phenotypes including hypoketonemia, hypoglycemia, hyperammonemia, and impaired neurologic, cardiac and skeletal muscle performance, each of which is apparent in mice lacking SRC-3 expression. Consistent with human cases of CACT deficiency, dietary rescue with short chain fatty acids drastically attenuates the clinical hallmarks of the disease in mice devoid of SRC-3. Collectively, our results position SRC-3 as a key regulator of β-oxidation. Moreover, these findings allow us to consider platform coactivators such as the SRCs as potential contributors to syndromes such as CACT deficiency, previously considered as monogenic.

Indexed as

AnimalsCarnitine AcyltransferasesFatty AcidsGene Expression RegulationHumansHyperammonemiaHypoglycemiaKetosisLipid MetabolismMaleMiceMice, TransgenicMuscle, SkeletalMuscular DiseasesNuclear Receptor Coactivator 3Oxidation-ReductionCarnitine AcyltransferasesFatty AcidsNuclear Receptor Coactivator 3

Identifiers

PMID22560224
PMCPMC3349072
OpenAlexW1985397492

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.